Complementary diagnostic lateral flow assays may assist therapeutic decisions alongside other companion diagnostics.
A lateral flow test can monitor levels of circulating biomarkers linked to a condition, measure Therapeutic Monoclonal Antibodies (mAb) in patient samples to help optimise drug delivery, or monitor patient antibodies, including anti-drug antibodies (ADAs), directed against the Therapeutic mAb to manage drug efficacy.
With new therapeutic antibody drugs in development and an increase in the number of biosimilars, a lateral flow device can assist laboratories and doctors in monitoring patient treatments.
Abingdon Health’s experience of working with different markers and sample matrices means we can assist in the development of these Complementary Diagnostic lateral flow assays.
If you are a pharma company looking to add value to your therapeutic, a diagnostic company looking to extend your ELISA range, or have a novel diagnostic challenge where a lateral flow assay could help, please contact a member of our team on +44 (0) 1904 406080 or firstname.lastname@example.org.
© Abingdon Health 2017